The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer

The gastrointestinal microbiome has been shown to play a key role in determining the responses to cancer immunotherapy, including immune checkpoint inhibitor (ICI) therapy and CAR-T. In patients with non-small cell lung cancer (NSCLC), increasing evidence suggests that a microbiome composition signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Duttagupta, Sreya, Hakozaki, Taiki, Routy, Bertrand, Messaoudene, Meriem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669980/
https://www.ncbi.nlm.nih.gov/pubmed/37999101
http://dx.doi.org/10.3390/curroncol30110681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669980/
https://www.ncbi.nlm.nih.gov/pubmed/37999101
http://dx.doi.org/10.3390/curroncol30110681

Ejemplares similares